Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Short-term Investments (2020 - 2025)

Cellebrite DI's Short-term Investments history spans 6 years, with the latest figure at $161.0 million for Q4 2025.

  • Quarterly Short-term Investments rose 4.75% to $161.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $161.0 million through Dec 2025, up 4.75% year-over-year, with the annual reading at $161.0 million for FY2025, 4.75% up from the prior year.
  • Short-term Investments came in at $161.0 million for Q4 2025, up from $153.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $161.0 million in Q4 2025 to a low of $7.8 million in Q1 2021.
  • The 5-year median for Short-term Investments is $38.7 million (2023), against an average of $57.6 million.
  • Year-over-year, Short-term Investments crashed 41.16% in 2022 and then soared 297.35% in 2024.
  • Cellebrite DI's Short-term Investments stood at $47.1 million in 2021, then dropped by 5.27% to $44.6 million in 2022, then decreased by 13.33% to $38.7 million in 2023, then skyrocketed by 297.35% to $153.7 million in 2024, then grew by 4.75% to $161.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Short-term Investments are $161.0 million (Q4 2025), $153.7 million (Q4 2024), and $38.7 million (Q4 2023).